DAFTAR PUSTAKA

1. Hashemi M., Sahadi A., Mahboubeh E., Seyed M., Javad Y., Ebrahim E., et all.
(2014). Association Between LAPTM4B Gene Polymorphism and Breast
Cancer Susceptibility in an Iranian Population. New York : Med Oncol. h1-2.
2. Shaker O., Fatma T., Maha S., Mohamed E. (2015). LAPTM4B Gene
Expression and Polymorphism As Diagnostic Markers of Breast Cancer In
Egyptian Patients. Cairo: Journal of Medical Biochemistry.h2
3. Li Y., Dirk I., Andrea L., Zhigang C. (2015). The Amplified Cancer Gene
LAPTM4B Promotes Tumor Growth and Tolerance to Stress Through The
Induction of Autophagy. USA : Harvard Medical School.h1-2
4. Xiao M., Shanshan Y., FanLing m., Yu Q., Yue Y., Shusheng J., et all. (2017).
LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and
Promotes Breast Cancer Cell Aggressiveness in Vitro. China: S. Karger AG,
Basel.h8-9
5. Chen D., Yanli C., Jianjun X., Qingyun Z. (2016). Relationship Between
LAPTM4B Gene Polymorphism and Susceptibility of Renal Cell Carcinoma
and Bladder Cancer. China : Journal of Clinical Laboratory.p7
6. Xiao M., Shusheng J., Hongbin W., Jinsong W., Yuanxi H., Zhigao L. (2013).
Overexpression of LAPTM4B: An Independent Prognostic Marker in Breast
Cancer. China: Springer.p7
7. Fadjari H. (2012). Pendekatan Diagnosis Benjolan di Payudara. Bandung :
RSUP Hasan Sadikin.h1-3
8. Ayu G., Lucia Y. (2015). Analisis Risiko Kanker Payudara Berdasar Riwayat
Pemakaian Kontrasepsi Hormonal dan Usia Menarche. Surabaya: Jurnal
Berkala Epidemiologi.h
9. Wijaya C., Tjakra W. (2017). Hubungan Subtipe Imunohistokimia dengan Usia
pada Pasien Kanker Payudara Di RSUP Sanglah Kota Denpasar. Bali: E-Jurnal
Medika.h
10. Farri E.(2017). Faktor yang Berpengaruh Terhadap Kondisi Grade Kanker
Payudara di Rumah Sakit Onkologi Surabaya Menggunakan Regresi Logistik
Ordinal. Surabaya : ITS.
11. Farahdiba B., Yusuf S. (2016). Klasifikasi Kanker Payudara Menggunakan
Algoritma Gain Ratio. Surakarta: Jurnal Teknik Elektro.h
12. Kabel A., Fahad H. (2015). Breast Cancer: Insights into Risk Factors,
Pathogenesis, Diagnosis and Management. Egypt : Journal of Cancer Research
and Treatment.h28-33
13. Permana C., Tjakra W. (2015). Hubungan Subtipe Imunohistokimia dengan
Usia Pada Pasien Kanker Payudara Di Rsup Sanglah Kota Denpasar. Bali : E-
Jurnal Medika.
14. Hendrik., Soehartati G., Zubairi D., Nurjati C., Evert D., Poetiray. (2012).
Kesintasan Hidup dan Kekambuhan Lokoregional Berdasarkan Prosedur
Pengobatan Pada Penatalaksanaan Kanker Payudara Stadium Lanjut Lokal.
Jakarta : Journal of the Indonesian Radiation Oncology Society.h11
15. Parikesit A., Dito A. (2018). Kajian Prediksi 3-Dimensi Biomarker Kanker
Payudara dari Jalur Ekspresi Lincrna-Ror/Mir-145/Arf6. Yogyakarta : Jurnal
Sains dan Teknologi.

16. Kong X., Xi C., Liyu J., Tingting M., Baosan H., Qifeng Y. (2016). Periareolar
Incision For The Management of Benign Breast Tumors. China : Oncology
Letter.

17. Panduan Penatalaksanaan Kanker Payudara. Kementerian Kesehatan Republik

Indonesia.

18. J

19. Kurniawan A., Nugroho P. (2012). Tata Laksana Kanker Payudara Relaps.
Jakarta: Indonesian Journal of Cancer.

20. Shah R., Kelly R., David N. (2014). Pathogenesis, Prevention, Diagnosis and
Treatment of Breast Cancer. Detroit : World Journal of Clinical Oncology